Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Lung cancer

See realtime coverage

Could a Lung Cancer Drug Work Better With Cok...

WebMD - ‎4 hours ago‎
12, 2016 (HealthDay News) -- Patients with the leading form of lung cancer may be able to look to Coca-Cola Classic to solve a common medicinal challenge, new research suggests.

Small-Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 2016-2018 - Research ...

Business Wire (press release) - ‎7 hours ago‎
Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

Early Data for Combo Immunotherapy in Lung Cancer

Medscape - ‎Feb 11, 2016‎
The combination of two investigational checkpoint inhibitors demonstrated antitumor activity in patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC), according to results from an early phase 1b trial published online February ...

SEND ANOTHER EMAIL CLOSE

BostInno - ‎Feb 11, 2016‎
Right now, the most common method to screen for lung cancer is the CT scan, which presents more cons than pros. For one thing, CT scans are super expensive for hospitals and have to be booked well in advance, so only a fraction of patients at risk of ...

New Lung Cancer Trial Opened in New Mexico

Latinos Health - ‎6 hours ago‎
BALTIMORE - AUGUST 15: In this photo illustration, leading chemotherapy treatments for lung cancer patients are displayed at the Kimmel Comprehensive Cancer Center at Johns Hopkins hospital August 15, 2005 in Baltimore, Maryland.

Roche to Stop Study on Lung Cancer Drug Alecensa Early

Nasdaq - ‎Feb 11, 2016‎
Roche Holding AGRHHBY announced that its Japanese subsidiary, Chugai Pharmaceutical Co., Ltd., has received a recommendation from an independent data monitoring committee to stop the ongoing phase III study, J-ALEX, on its lung cancer drug, ...
See realtime coverage

AstraZeneca's cancer checkpoint combo looks promising in small lung cancer study

FierceBiotech - ‎Feb 8, 2016‎
AstraZeneca ($AZN) has successfully wrapped a small proof-of-concept study to help demonstrate how two immunotherapy drugs will likely work better than one.

Lung cancer expert named to NCI board

Healio - ‎4 hours ago‎
“This appointment is in recognition of Dr. Perez-Soler's leadership and notable, innovative laboratory and clinical research contributions on the prevention and treatment of lung cancer,” I. David Goldman, MD, director of Albert Einstein Cancer Center ...

Bonnie J. Addario Lung Cancer Foundation Honors Medtronic for Improving Diagnostic Tools for Lung Cancer

PR Newswire (press release) - ‎Feb 11, 2016‎
SAN CARLOS, Calif., Feb. 11, 2016 /PRNewswire-USNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (ALCF) awarded Medtronic the "Simply the Best" award at the ALCF's tenth annual "Simply the Best" Gala for demonstrating commitment to ...

Leading the Effort to Improve Early Detection of Lung Cancer in Kentucky

3BL Media (press release) - ‎7 hours ago‎
For the past 18 months, a collaborative effort among Kentucky's leading research universities, community partners and national organizations has been looking at how the state known for the highest lung cancer burden in the nation can become a leader in ...

First-line Afatinib Benefits Lung Cancer Patients With Brain Metastases

Oncology Nurse Advisor - ‎Feb 11, 2016‎
Afatinib has clinical activity in patients with non-small cell lung cancer (NSCLC) who have epidermal growth factor (EGFR) mutations and brain metastases.

Radiology guidelines have reduced variability in lung cancer screening strategies

Healio - ‎Feb 11, 2016‎
Most leading U.S. academic medical centers use the same radiology guidelines and nodule threshold criteria within their lung cancer screening practices since the issuance of guidelines from the American College of Radiology, according to survey results.

Lung Cancer Therapeutics Market (2015 to 2021) – The report provides in-depth analysis of parent market trends ...

Medgadget.com (blog) - ‎15 hours ago‎
logo2128 Cancer is a disease of genes which are caused due to abnormal growth of cells. These abnormal cells further migrate from the original site to other site through blood and lymph system.

Molecular Brake Stifles Human Lung Cancer

Doctor Tipster - ‎Feb 11, 2016‎
A new research published recently in PNAS has revealed that researchers at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans. The molecule they have ...

Want to Prevent Lung Cancer? Get Higher

dailyRx News - ‎Feb 11, 2016‎
In this study, doctoral students from the University of Pennsylvania (UPenn) and the University of California, San Francisco (UCSF) studied the possibility that higher altitudes could not only prevent lung cancer, but that the amount of oxygen in the ...

Clinical Trial Offers New Drug Combo to Fight Lung Cancer

Newswise (press release) - ‎Feb 9, 2016‎
Newswise - The 1,000 people in New Mexico fighting lung cancer may soon be able to breathe easier. The first of more than 10 new lung cancer clinical trials has just opened under the direction of Yanis Boumber, MD, PhD. Boumber is a lung cancer expert ...
See realtime coverage

AstraZeneca Wins European Approval for Lung Cancer Drug Tagrisso

Wall Street Journal - ‎Feb 3, 2016‎
AstraZeneca on Wednesday said European regulators have approved a potential blockbuster lung cancer drug that the company hopes will form a key plank of its growth plans.

EpiCast Report: Small Cell Lung Cancer - Epidemiology Forecast to 2024 - Research and Markets

Business Wire (press release) - ‎Feb 11, 2016‎
Epidemiologists forecast that the diagnosed incident cases of SCLC will increase from 79,077 cases in 2014 to 91,640 cases in 2024 across the 7MM with an Annual Growth Rate (AGR) of 1.59%.

TV Ads for Lung Cancer Drug Are Needed, Says BMS

Medscape - ‎Feb 2, 2016‎
Direct-to-consumer (DTC) advertisements for nivolumab (Opdivo, Bristol-Myers Squibb) as a lung cancer treatment, currently airing on American television and appearing in print and online, have been criticized for having an efficacy claim that is vague ...
 -